Walleye Capital LLC

Position in NVO — Novo Nordisk A S

CIK 1758720 NEW YORK, NY

Back to NVO Full portfolio

Position in NVO

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$9,307,982

-$11,944,873 QoQ

Shares Held

194,159

-66.4% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#156

of 1,348 holders

Holding Since

Sep 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Derivatives in NVO

reported options exposure · as of Jun 30, 2026

CallValue

$6,630,102

CallShares

138,300

PutValue

$16,184,544

PutShares

337,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $213,456,876 across 14 Drug Manufacturers - General names. NVO ranks #5 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	240,318	$87,023,954
2	PFE	Pfizer Inc	2,417,136	$58,204,634
3	LLY	ELI LILLY & Co	28,457	$34,132,182
4	GSK	GSK plc	402,472	$21,097,582
5	NVO	Novo Nordisk A S This page	194,159	$9,307,982
6	SNY	Sanofi	33,051	$1,409,955
7	BMY	Bristol Myers Squibb Co	18,084	$1,042,000
8	JNJ	Johnson & Johnson	1,394	$354,034

All Filings in NVO

Export CSV

42 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,307,982	194,159	-66.4%	Shares	Sole	2026-08-03
2026-06-30	$16,184,544	337,600	-21.0%	Put	Sole	2026-08-03
2026-06-30	$6,630,102	138,300	-22.3%	Call	Sole	2026-08-03
2026-03-31	$6,545,175	178,100	-54.4%	Call	Sole	2026-05-13
2026-03-31	$21,252,855	578,309	+15.5%	Shares	Sole	2026-05-13
2026-03-31	$15,703,275	427,300	-36.6%	Put	Sole	2026-05-13
2025-12-31	$19,883,904	390,800	+105.7%	Call	Sole	2026-02-13
2025-12-31	$34,267,680	673,500	+127.8%	Put	Sole	2026-02-13
2025-12-31	$25,472,766	500,644	+248.2%	Shares	Sole	2026-02-13
2025-09-30	$16,402,844	295,600	+29.8%	Put	Sole	2025-11-14
2025-09-30	$10,543,100	190,000	-30.6%	Call	Sole	2025-11-14
2025-09-30	$7,977,519	143,765	+513346.4%	Shares	Sole	2025-11-14
2025-06-30	$15,722,756	227,800	+25.6%	Put	Sole	2025-08-13
2025-06-30	$18,897,676	273,800	+22.5%	Call	Sole	2025-08-13
2025-06-30	$1,932	28	-100.0%	Shares	Sole	2025-08-13
2025-03-31	$15,519,840	223,500	+28.0%	Call	Sole	2025-05-14
2025-03-31	$13,259,845	190,954	+17.8%	Shares	Sole	2025-05-14
2025-03-31	$12,589,472	181,300	+24.8%	Put	Sole	2025-05-14
2024-12-31	$12,498,706	145,300	+25.0%	Put	Sole	2025-02-13
2024-12-31	$15,019,092	174,600	+203.7%	Call	Sole	2025-02-13
2024-12-31	$13,942,723	162,087	-35.7%	Shares	Sole	2025-02-13
2024-09-30	$29,996,828	251,926	+37.9%	Shares	Sole	2024-11-14
2024-09-30	$13,835,934	116,200	-55.3%	Put	Sole	2024-11-14
2024-09-30	$6,846,525	57,500	-30.9%	Call	Sole	2024-11-14
2024-06-30	$11,875,968	83,200	-32.3%	Call	Sole	2024-08-14
2024-06-30	$37,083,852	259,800	+68.7%	Put	Sole	2024-08-14
2024-06-30	$26,076,456	182,685	+74.7%	Shares	Sole	2024-08-14
2024-03-31	$15,780,360	122,900	+70.7%	Call	Sole	2024-05-15
2024-03-31	$19,773,600	154,000	-1.6%	Put	Sole	2024-05-15
2024-03-31	$13,424,348	104,551	-24.6%	Shares	Sole	2024-05-15
2023-12-31	$14,339,825	138,616	-28.1%	Shares	Sole	2024-02-14
2023-12-31	$16,189,925	156,500	+31.4%	Put	Sole	2024-02-14
2023-12-31	$7,448,400	72,000	+65.1%	Call	Sole	2024-02-14
2023-09-30	$3,964,984	43,600	-11.6%	Call	Sole	2023-11-21
2023-09-30	$10,830,954	119,100	+223.6%	Put	Sole	2023-11-21
2023-09-30	$17,532,777	192,795	—	Shares	Sole	2023-11-21
2023-06-30	$5,955,344	36,800	+484.1%	Put	Sole	2023-08-14
2023-06-30	$7,978,219	49,300	+604.3%	Call	Sole	2023-08-14
2023-03-31	$1,002,582	6,300	-75.0%	Put	Sole	2023-05-15
2023-03-31	$1,113,980	7,000	+25.0%	Call	Sole	2023-05-15
2022-09-30	$557,928	5,600	—	Call	Sole	2022-11-14
2022-09-30	$2,510,676	25,200	—	Put	Sole	2022-11-14
No filing history on record for this holder in this stock.